Literature DB >> 33260834

BCG Vaccination Status, Age, and Gender as Risk Factors for Leprosy in Endemic Areas in the Brazilian Amazon.

Luana Nepomuceno Gondim Costa Lima1,2, Jasna Letícia Pinto Paz2, Maria do Perpétuo Socorro Corrêa Amador Silvestre1, Letícia Siqueira Moura1, Ismari Perini Furlaneto3, Karla Valéria Batista Lima1,2.   

Abstract

In 2018, 208,619 new cases of leprosy were reported to the World Health Organization (WHO). Of these, 30,957 occurred in the Americas region and 28,660 (92.6% of the total in the Americas) were reported in Brazil. This study aimed to show the reality of the profile of a population in an endemic leprosy area in northern Brazil in relation to age, gender, and bacillus Calmette-Guérin (BCG) vaccination status through the collection of data in the field with the evaluation of the study individuals, who were recruited by spontaneous demand. A total of 405 individuals participated in the study, with 100 multibacillary, 57 paucibacillary, and 248 healthy contacts. A relationship was observed between the occurrence of the disease, as well as the multibacillary form with the largest age group. The male gender was associated with leprosy per se, with the multibacillary form and was the largest representative of the group that was not vaccinated once. BCG vaccination was effective both in protecting against leprosy per se and in the multibacillary form. These results are limited by sample size, may not be conclusive, and will need further confirmation in a larger cohort.

Entities:  

Keywords:  BCG; epidemiology; leprosy; mycobacterium leprae

Year:  2020        PMID: 33260834     DOI: 10.3390/idr12030019

Source DB:  PubMed          Journal:  Infect Dis Rep        ISSN: 2036-7430


  1 in total

1.  Pediatric Leprosy Profile in the Postelimination Era: A Study from Surabaya, Indonesia.

Authors:  Novianti Rizky Reza; Bagus Hario Kusumaputro; Medhi Denisa Alinda; Muhammad Yulianto Listiawan; Hok Bing Thio; Cita Rosita Sigit Prakoeswa
Journal:  Am J Trop Med Hyg       Date:  2022-01-10       Impact factor: 3.707

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.